List of Software Companies in Belgium - 4

MyCellHub.com - Digital GMP workflows MyCellHub provides a toolkit for the digitalisation, data integration and data analytics of regulated laboratory and cleanroom workflows. More than 90% of biotech and (bio)pharmaceutical companies currently create production reports on paper. It's time to accelerate the launch of new therapies and not be held back anymore by paperwork.

N-SIDE is a world leader in increasing the efficiency of life sciences and energy industries by providing software and services that optimize the use of natural resources, facilitating the transition to a more sustainable world. To achieve this, N-SIDE leverages its deep industry knowledge, technical expertise, and understanding of applied mathematics to help global pharmaceutical and energy companies anticipate, adapt, and optimize their decisions. In the life sciences industry, N-SIDE reduces waste in clinical trials, leading to more efficient, faster, and more sustainable clinical trials. In the energy industry, N-SIDE helps electricity market and grid operators in enabling a safer and faster transition toward renewable sources. N-SIDE is driven by a diverse team of over 200 passionate engineers, computer scientists, and business experts from 30+ different nationalities, including individuals with advanced academic qualifications such as PhDs. Together, they are committed to making a meaningful impact toward a more sustainable future. N-SIDE is headquartered in Belgium with offices in the USA and Japan. The company is certified B Corporation, Best Managed Company by Deloitte Belgium, ISO 14001 and ISO 27001.

Nuclivision is a Belgian healthtech startup founded in 2022 and based in Ghent. The company specializes in developing software solutions for nuclear medicine, focusing on positron emission tomography (PET) imaging. Its mission is to enhance the efficiency and safety of PET scans, which are vital for diagnosing and treating conditions like cancer and Alzheimer's disease. The flagship product, Nuclarity, is an AI-powered software that improves PET imaging workflows. It employs advanced image enhancement algorithms to allow for lower-dose PET scans without sacrificing image quality or diagnostic accuracy. This technology reduces scan times and radiation exposure, making PET scans safer and more accessible. Nuclarity integrates into existing clinical workflows, supporting the entire process from image acquisition to interpretation and follow-up. Nuclivision has attracted investment from notable sources, including LUMO Labs and Heran Partners, to support its growth and development. The company aims to launch Nuclarity in Europe and the U.S. and expand its team to meet the increasing demand for PET imaging solutions.

OncoDNA is a genomic and theranostic company specializing in precision medicine for the treatment of cancer and genetic diseases. The company helps clinicians, academic researchers and biopharma companies to outsmart molecular complexity with the mission of delivering the promise of precision medicine. The company not only provides clinical guidance for the treatment and real-time monitoring of late-stage cancer patients but also supports research and drug development in cancer and genetic diseases. Since its early days in 2012, OncoDNA has grown into a corporate group of companies with world-renowned expertise. The Group offers a unique portfolio that combines NGS services, biomarker testing, data interpretation software, and clinical decision support tools. OncoDNA is headquartered in Belgium, and its entities – Biosequence and IntegraGen – are based in Spain, France and the United States. The Group employs over 100 employees across 9 countries, works with an international network of 35 distributors and collaborates with both European-based and US-based subcontracted accredited laboratories.